Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11752211 Fatty acids and their use in conjugation to biomolecules

Patent 11752211 was granted and assigned to Novartis on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11752211

Patent Inventor Names

Aaron Kanter

Aimee Richardson Usera

Frederic Zecri

Jun Yuan

Alexandra Marshall Bruce

Date of Patent

September 12, 2023

Patent Application Number

16889201

Date Filed

June 1, 2020

Patent Citations

‌

US Patent 9067971 Synthetic apelin mimetics for the treatment of heart failure

‌

US Patent 7157235 Methods of diagnosis, prognosis and treatment of cardiovascular disease

‌

US Patent 8192735 Method for modulating appetite

‌

US Patent 8673848 Synthetic apelin mimetics for the treatment of heart failure

‌

US Patent 8921307 Synthetic linear apelin mimetics for the treatment of heart failure

‌

US Patent 8946146 Method for modulating appetite

‌

US Patent 9931372 Synthetic apelin fatty acid conjugates with improved half-life

‌

US Patent 9956264 MIC-1 fusion proteins and uses thereof

...

Patent Primary Examiner

‌

Ronald T Niebauer

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11752211 Fatty acids and their use in conjugation to biomolecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API